VTYX
Price:
$2.24
Market Cap:
$158.30M
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of syst...[Read more]
Industry
Biotechnology
IPO Date
2021-10-21
Stock Exchange
NASDAQ
Ticker
VTYX
According to Ventyx Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -54.94%. This represents a change of 294.16% compared to the average of -13.94% of the last 4 quarters.
The mean historical ROE of Ventyx Biosciences, Inc. over the last ten years is 47.31%. The current -54.94% ROE has changed -216.12% with respect to the historical average. Over the past ten years (40 quarters), VTYX's ROE was at its highest in in the March 2021 quarter at 122.81%. The ROE was at its lowest in in the December 2023 quarter at -19.17%.
Average
47.31%
Median
66.53%
Minimum
-79.11%
Maximum
108.36%
Discovering the peaks and valleys of Ventyx Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 108.36%
Minimum Annual Increase = -265.77%
Minimum Annual ROE = -79.11%
Year | ROE | Change |
---|---|---|
2023 | -79.11% | -265.77% |
2022 | 47.72% | -28.27% |
2021 | 66.53% | -28.53% |
2020 | 93.08% | -14.10% |
The current ROE of Ventyx Biosciences, Inc. (VTYX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.71%
5-year avg
47.31%
10-year avg
47.31%
Ventyx Biosciences, Inc.’s ROE is greater than Arcellx, Inc. (-8.28%), greater than Immunocore Holdings plc (-14.67%), greater than Vaxcyte, Inc. (-23.53%), greater than DICE Therapeutics, Inc. (-102.37%), greater than Nuvalent, Inc. (-28.83%), greater than Cerevel Therapeutics Holdings, Inc. (-98.94%), greater than Travere Therapeutics, Inc. (-541.59%), greater than Structure Therapeutics Inc. (-20.15%), less than Replimune Group, Inc. (0%), greater than Ascendis Pharma A/S (-52.15%), less than United Therapeutics Corporation (251.76%), less than IDEAYA Biosciences, Inc. (19.22%), greater than Protagonist Therapeutics, Inc. (-19.42%), less than Verona Pharma plc (85.47%), greater than Syndax Pharmaceuticals, Inc. (-79.64%), greater than null (-64.34%),
Company | ROE | Market cap |
---|---|---|
-8.28% | $5.33B | |
-14.67% | $1.72B | |
-23.53% | $12.51B | |
-102.37% | $2.27B | |
-28.83% | $6.57B | |
-98.94% | $8.19B | |
-541.59% | $1.38B | |
-20.15% | $2.19B | |
0% | $834.20M | |
-52.15% | $7.26B | |
251.76% | $17.97B | |
19.22% | $2.53B | |
-19.42% | $2.80B | |
85.47% | $3.12B | |
-79.64% | $1.83B | |
-64.34% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ventyx Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ventyx Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ventyx Biosciences, Inc.'s ROE?
How is the ROE calculated for Ventyx Biosciences, Inc. (VTYX)?
What is the highest ROE for Ventyx Biosciences, Inc. (VTYX)?
What is the 3-year average ROE for Ventyx Biosciences, Inc. (VTYX)?
What is the 5-year average ROE for Ventyx Biosciences, Inc. (VTYX)?
How does the current ROE for Ventyx Biosciences, Inc. (VTYX) compare to its historical average?